GD
ARRY

Grandfield & Dodd’s Array Biopharma Inc ARRY Stock Holding History

Grandfield & Dodd’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,965
Closed -$369K – 183
2019
Q2 		$369K Buy
+7,965
New +$224K 0.04% 142

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Grandfield & Dodd's ARRY Position: Q3 2019 in Review

Grandfield & Dodd sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 7,965 shares — an estimated $369K sold.

Grandfield & Dodd first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $369K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Grandfield & Dodd reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Grandfield & Dodd sold 7,965 Array Biopharma Inc shares in Q3 2019, an estimated $369K.
  • Grandfield & Dodd first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Grandfield & Dodd's Array Biopharma Inc position peaked at $369K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Grandfield & Dodd's 13F filing for Q3 2019, filed 30 Oct 2019.